검색어 : 통합검색[Cancer drug discovery and development]
총 10,586건 중 1,000건 출력
, 98/100 페이지
-
971
- [Chemical evaluation by cancer cell line panel and its role in molecular target-based anticancer drug screening]
- Yamori, Takao; ; (癌と化學療法 = Cancer & chemotherapy, v.31, 2004, pp.485-490)
-
972
- Key factors influencing ADME properties of therapeutic proteins: A need for ADME characterization in drug discovery and development
- Tibbitts, Jay; Canter, David; Graff, Ryan; Smith, Alison; Khawli, Leslie A.; UCB Celltech, Slough, SL1 3WE, UK; Department of Pathology, Keck School of Medicine of the University of Southern California , Los Angeles, CA, USA; Department of Pathology, Keck School of Medicine of the University of Southern California , Los Angeles, CA, USA; Department of Pathology, Keck School of Medicine of the University of Southern California , Los Angeles, CA, USA; Department of Pathology, Keck School of Medicine of the University of Southern California , Los Angeles, CA, USA; (mAbs, v.8, 2016, pp.229-245)
-
973
- Quantitative determination of enzalutamide, an anti‐prostate cancer drug, in rat plasma using liquid chromatography–tandem mass spectrometry, and its application to a pharmacokinetic study
- Song, Ji‐ Hye; Kim, Tae‐ Heon; Jung, Jong‐ Woo; Kim, Nakjeong; Ahn, Sung Hoon; Hwang, Sung‐ Ook; Kang, Nam Sook; Yoo, Sung‐ Eun; Koo, Tae‐ Sung; Graduate School of New Drug Discovery and Development, Chungnam National University, Daejeon, Korea; Graduate School of New Drug Discovery and Development, Chungnam National University, Daejeon, Korea; Graduate School of New Drug Discovery and Development, Chungnam National University, Daejeon, Korea; Division of Bio‐ organic Science, Korea Research Institute of Chemical Technology, Daejeon, Korea; Division of Bio‐ organic Science, Korea Research Institute of Chemical Technology, Daejeon, Korea; Department of Obstetrics and Gynecology, Inha University Hospital, Incheon, Korea; Graduate School of New Drug Discovery and Development, Chungnam National University, Daejeon, Korea; Graduate School of New Drug Discovery and Development, Chungnam National University, Daejeon, Korea; Graduate School of New Drug Discovery and Development, Chungnam National University, Daejeon, Korea; (Biomedical chromatography : BMC, v.28, 2014, pp.1112-1117)
-
974
- The Future of Clinical Trial Design in Oncology
- Spreafico, Anna; Hansen, Aaron R.; Abdul Razak, Albiruni R.; Bedard, Philippe L.; Siu, Lillian L.; Division of Medical Oncology and Hematology, Drug Development Program, Princess Margaret Cancer Centre, University Health Network, Toronto, Canada.; Division of Medical Oncology and Hematology, Drug Development Program, Princess Margaret Cancer Centre, University Health Network, Toronto, Canada.; Division of Medical Oncology and Hematology, Drug Development Program, Princess Margaret Cancer Centre, University Health Network, Toronto, Canada.; Division of Medical Oncology and Hematology, Drug Development Program, Princess Margaret Cancer Centre, University Health Network, Toronto, Canada.; Division of Medical Oncology and Hematology, Drug Development Program, Princess Margaret Cancer Centre, University Health Network, Toronto, Canada.; (Cancer discovery, v.11, 2021, pp.822-837)
-
975
- The targeted delivery of cancer drugs across the blood–brain barrier: chemical modifications of drugs or drug-nanoparticles?
- Juillerat-Jeanneret, Lucienne; CHUV-UNIL, Lausanne, Switzerland; (Drug discovery today, v.13, 2008, pp.1099-1106)
-
976
- Abstract 1864: Generation of a triple-mutation (T790M/C797S/L858R) NSCLC cell line for relevant drug discovery and development
- Ma, Huiying; Li, Peixue; Zhang, Peiran; Sun, Fuyun; Lin, Qing; ; (Cancer research : the official organ of the American Association for Cancer Research, Inc, v.80, 2020, pp.1864-1864)
-
977
- Drug Repositioning and Response Detection Based on Randomized Control Trials for Cancer Treatment - A Review
- ; ; (Journal of angiotherapy, v.7, 2023, )
-
978
- Discovery of First-in-Class Small Molecule Inhibitors of Lymphocyte Activation Gene 3 (LAG-3)
- Abdel-Rahman, Somaya A.; Rehman, Ashfaq Ur; Gabr, Moustafa T.; Department of Radiology, Molecular Imaging Innovations Institute (MI3) , Weill Cornell Medicine , New York , New York 10065 , United States; Department of Molecular Biology and Biochemistry , University of California, Irvine , Irvine , California 92697 , United States; (ACS medicinal chemistry letters, v.14, 2023, pp.629-635)
-
979
- Abstract 1077: Porcupine inhibition enhances enzalutamide efficacy in drug resistant prostate cancer
- Jones, Katelyn Makayla; Liu, Xiaoqi; 1University of Kentucky, Lexington, KY.; 1University of Kentucky, Lexington, KY.; (Cancer research : the official organ of the American Association for Cancer Research, Inc, v.83, 2023, pp.1077-1077)
-
980
- Glutathione-Responsive Prodrug Nanoparticles for Effective Drug Delivery and Cancer Therapy
- Ling, Xiang; Tu, Jiasheng; Wang, Junqing; Shajii, Aram; Kong, Na; Feng, Chan; Zhang, Ye; Yu, Mikyung; Xie, Tian; Bharwani, Zameer; Aljaeid, Bader M.; Shi, Bingyang; Tao, Wei; Farokhzad, Omid C.; Center for Nanomedicine and Department of Anesthesiology, Brigham and Women’s Hospital , Harvard Medical School , Boston , Massachusetts 02115 , United States; Center for Research Development and Evaluation of Pharmaceutical Excipients and Generic Drugs, Department of Pharmaceutics, State Key Laboratory of Natural Medicines , China Pharmaceutical University , Nanjing , Jiangsu 210009 , China; Center for Nanomedicine and Department of Anesthesiology, Brigham and Women’s Hospital , Harvard Medical School , Boston , Massachusetts 02115 , United States; Center for Nanomedicine and Department of Anesthesiology, Brigham and Women’s Hospital , Harvard Medical School , Boston , Massachusetts 02115 , United States; Center for Nanomedicine and Department of Anesthesiology, Brigham and Women’s Hospital , Harvard Medical School , Boston , Massachusetts 02115 ,; (ACS nano, v.13, 2019, pp.357-370)
QUICK MENU
